About
Axe Biostrategy is a specialist life sciences advisory firm that supports biotechnology stakeholders — including companies, academic institutions, inventors, not-for-profits, and investors — across business development, commercial strategy, and structured capital decision-making.
We help clients navigate complex strategic and transactional situations by combining clinical, commercial, and financial analysis with hands-on execution support. The firm has particular expertise in non-dilutive financing solutions such as royalty monetization and alternative structured capital strategies.
With unique expertise spanning management consulting, investing, and corporate strategy across the life sciences value chain, Axe Biostrategy provides independent, investor-grade analysis and process-execution support to help clients assess opportunities, evaluate risks, and unlock the full value of their assets.
Leadership
Meet the Principal behind Axe Biostrategy
Ben Axler
Ben Axler is a life sciences investor and strategic advisor with deep transactional and analytical experience across the life sciences ecosystem. As Principal of Axe Biostrategy, he partners with biotech companies, investors, foundations, research institutions, and inventors on commercialization planning, business development, and non-dilutive financing solutions.
Before founding Axe Biostrategy, Ben served as Senior Director at DRI Healthcare, where he originated, structured, and executed royalty financing transactions as part of the investment team. Prior to DRI, he was a strategy consultant with Promidian, supporting biopharma clients on commercial strategy and market access engagements. Earlier in his career, Ben held consulting roles with blue-chip life sciences companies, worked for a clinical trial research organization, and supported early-stage IP commercializaiton efforts for a university tech transfer office.
Education
MBS (MSc/MBA), Biotech Management – Keck Graduate Institute (KGI)
BSc, Honors Genetics & Biochemistry – University of Western Ontario (UWO)
